Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
INDUSTRY
×
Prostatic Neoplasms
×
Nivolumab
×
Clear all
Filters
3
NCT03338790
2026-01-27
CheckMate 9KD
Bristol-Myers Squibb
Phase 2
Completed
292 enrolled
21 charts
NCT02985957
2025-12-22
CheckMate 650
Bristol-Myers Squibb
Phase 2
Completed
351 enrolled
43 charts
NCT04100018
2025-06-12
CheckMate 7DX
Bristol-Myers Squibb
Phase 3
Completed
1,030 enrolled
25 charts
NCT02009449
2024-11-15
IVY
Eli Lilly and Company
Phase 1
Completed
353 enrolled
NCT00441337
2015-02-20
MDX1106-01
Bristol-Myers Squibb
Phase 1
Completed
39 enrolled
28 charts